These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 20230279)
1. Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway. Yu S; Zheng W; Xin N; Chi ZH; Wang NQ; Nie YX; Feng WY; Wang ZY Rejuvenation Res; 2010 Feb; 13(1):55-64. PubMed ID: 20230279 [TBL] [Abstract][Full Text] [Related]
2. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. Saporito MS; Brown EM; Miller MS; Carswell S J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541 [TBL] [Abstract][Full Text] [Related]
3. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease. Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516 [TBL] [Abstract][Full Text] [Related]
4. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta. Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023 [TBL] [Abstract][Full Text] [Related]
5. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease]. Wang YS; Zhou JP; Wei ZF; Tian QY; Zhou HX; Zhang YX Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1199-202, 1205. PubMed ID: 17715026 [TBL] [Abstract][Full Text] [Related]
6. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats. Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221 [TBL] [Abstract][Full Text] [Related]
7. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid. Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508 [TBL] [Abstract][Full Text] [Related]
8. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447 [TBL] [Abstract][Full Text] [Related]
9. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice. Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132 [TBL] [Abstract][Full Text] [Related]
10. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease. Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138 [TBL] [Abstract][Full Text] [Related]
11. NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1. Yang HJ; Wang L; Xia YY; Chang PN; Feng ZW Neurochem Int; 2010 Jan; 56(1):128-34. PubMed ID: 19778565 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in the MPTP-induced mouse model of Parkinson's disease: Involvement of reactive oxygen species-mediated JNK, P38 and mitochondrial pathways. He H; Wang S; Tian J; Chen L; Zhang W; Zhao J; Tang H; Zhang X; Chen J Eur J Pharmacol; 2015 Nov; 767():175-82. PubMed ID: 26477638 [TBL] [Abstract][Full Text] [Related]
13. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Karunakaran S; Saeed U; Mishra M; Valli RK; Joshi SD; Meka DP; Seth P; Ravindranath V J Neurosci; 2008 Nov; 28(47):12500-9. PubMed ID: 19020042 [TBL] [Abstract][Full Text] [Related]
14. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Xia XG; Harding T; Weller M; Bieneman A; Uney JB; Schulz JB Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10433-8. PubMed ID: 11504916 [TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway. Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson C; Wolf CR; Gama MJ Mol Neurobiol; 2012 Jun; 45(3):466-77. PubMed ID: 22539231 [TBL] [Abstract][Full Text] [Related]
16. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway. Zhai A; Zhu X; Wang X; Chen R; Wang H Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112 [TBL] [Abstract][Full Text] [Related]
17. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not elicit long-lasting increases in cyclooxygenase-2 expression in dopaminergic neurons of monkeys. Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Belzunegui S; Izal-Azcárate A; López B; Marcilla I; Luquin MR J Neuropathol Exp Neurol; 2009 Jan; 68(1):26-36. PubMed ID: 19104449 [TBL] [Abstract][Full Text] [Related]
18. MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. Saporito MS; Thomas BA; Scott RW J Neurochem; 2000 Sep; 75(3):1200-8. PubMed ID: 10936203 [TBL] [Abstract][Full Text] [Related]